over-the counter
FDA Releases New Guidance on Oral Phenylephrine, Xlear Responds
On Nov. 7, the U.S. Food and Drug Administration (FDA) proposed removing oral phenylephrine from over the counter (OTC) medications due to “effectiveness concerns.” According to FDA, oral phenylephrine is widely used as an active ingredient in nasal decongestants. The agency conducted a comprehensive review of all available data on the safety and efficacy of ...
FDA Warns Selling of Topical CBD Products Violates FD&C Act
On March 22, the U.S. Food and Drug Administration stated that it has issued warning letters to two companies for selling topical pain relief products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the warning letters addressed the illegal marketing of unapproved drugs labeled ...
Operating a Health Food Retail Establishment in the Age of the Coronavirus
In the space of a few short weeks, what we thought of as our comfortable reality was changed; probably forever. In February, the most important thing was finding a potential pathway to market for CBD. By mid-March, everyone’s primary concern seemed to be a search for an adequate supply of toilet paper and perhaps washing ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!